Correlation Between Verve Therapeutics and Editas Medicine

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Editas Medicine, you can compare the effects of market volatilities on Verve Therapeutics and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Editas Medicine.

Diversification Opportunities for Verve Therapeutics and Editas Medicine

0.22

Correlation Coefficient

Verve Therapeutics  Editas Medicine

Modest diversification

The 3 months correlation between Verve and Editas is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Editas Medicine go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Editas Medicine

Given the investment horizon of 90 days Verve Therapeutics is expected to generate 0.99 times more return on investment than Editas Medicine. However, Verve Therapeutics is 1.01 times less risky than Editas Medicine. It trades about 0.03 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.14 per unit of risk. If you would invest  477.00  in Verve Therapeutics on August 26, 2024 and sell it today you would earn a total of  8.00  from holding Verve Therapeutics or generate 1.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Verve Therapeutics  vs.  Editas Medicine

Verve Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Verve Therapeutics is not utilizing all of its potentials. The newest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Editas Medicine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Verve Therapeutics and Editas Medicine

The main advantage of trading using opposite Verve Therapeutics and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.

The idea behind Verve Therapeutics and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.